Penumbra, Inc.

NYSE:PEN

Medical - Devices

Healthcare
$320.60 -0.72%

-$2.30 today

Market cap
$12.64B
Beta
0.70
P/E (TTM)
72.6
EPS (TTM)
$4.36
52W Low $221.26High $362.41

Volume 0.21M

Average 0.50M

PEN Net Margin

Net income as a percentage of revenue, showing how much of each sales dollar becomes profit.

Penumbra, Inc.NYSE: PEN

Net Margin · Q2 FY2026 · quarter ended Jun 2026

Net margin narrows to 8.9%

Net margin was 8.9% in Q2 FY2026, down 4.4 pp from a year earlier. On a trailing-twelve-month basis it was 10.7%, down 0.9 pp year over year. Over 3 fiscal years it widened by 12.9 pp.

Context

  • Net margin widened in 2 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

What to watch

Whether net margin reaches the consensus estimate from 6 analysts of 11.8% for the fiscal year ending Dec 2026, down from 12.7% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJun 2026
8.9%+0.2 pp QoQ
Last fiscal yearDec 2025
12.7%+11.5 pp YoY
LTMJun 2026
10.7%-0.9 pp YoY
Net Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-4.4 pp-1.0 pp+3.4 pp
1 year+11.5 pp-0.9 pp-12.4 pp
3 years+12.9 pp+1.3 pp-11.6 pp
5 years——
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Net Margin history

Percent of revenue · from the income statement

Latest · FY2025
12.7%
Year-over-year change
+11.5pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Net Margin vs competitors

How PEN compares with its peers on the latest reported figures

  • PEN's LTM Jun 2026 net margin of 10.7% is the 6th highest of the 9 companies compared; the peer median is 14.7%.
  • Its year-over-year change of -0.9 pp is the 6th highest of 9, against a peer median of +1.1 pp.
  • Over three fiscal years its change of +12.9 pp compares with a peer median of +1.6 pp.
PEN Competitors Peer median
Net Margin for PEN and competitors
Company Period LTM level YoY 3-year change
ISRGIntuitive Surgical, Inc.LTM Sep 202625.5% -3.0 pp+7.1 pp
LMATLeMaitre Vascular, Inc.LTM Mar 202624.3% +4.4 pp+10.4 pp
BSXBoston Scientific CorporationLTM Jun 202617.5% +3.9 pp+8.9 pp
EWEdwards Lifesciences CorporationLTM Jun 202615.4% -57.5 pp-10.6 pp
MDTMedtronic plcLTM Jul 202613.9% +0.3 pp+1.2 pp
PENPenumbra, Inc.LTM Jun 202610.7% -0.9 pp+12.9 pp
MMSIMerit Medical Systems, Inc.LTM Sep 20269.9% +1.9 pp+2.0 pp
ABTAbbott LaboratoriesLTM Sep 20269.7% -22.1 pp-1.2 pp
ANGOAngioDynamics, Inc.LTM Feb 2026-10.0% +4.6 pp-3.2 pp
Peer median (excluding PEN) 14.7%+1.1 pp+1.6 pp

Competitors are the stored peer set for PEN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue747.59M847.13M1.06B1.19B1.4B
Cost of Revenue272.21M311.93M375.88M439.62M461.23M
Gross Profit475.38M535.21M682.64M755M942.44M
Gross Margin63.6%63.2%64.5%63.2%67.1%
Research & Development104.55M79.41M84.42M94.78M89.77M
Selling, General & Admin378.33M449.72M506.45M573.99M663.42M
Operating Expenses482.88M529.13M609.09M668.77M753.19M
Depreciation & Amortization16.41M24.32M27.26M23.7M17.47M
EBITDA7.84M29.96M108.65M45.99M223.91M
EBITDA Margin1.0%3.5%10.3%3.8%16.0%
Operating Income(7.5M)6.08M73.55M86.22M189.25M
Operating Margin-1.0%0.7%6.9%7.2%13.5%
Interest Income2.87M1.89M6.83M13.69M16.29M
Interest Expense1.93M1.75M1.74M1.42M1.31M
Other Income / Expenses(3M)(2.19M)6.1M(65.36M)15.88M
Income Before Tax(10.5M)3.89M79.65M20.87M205.13M
Pre-Tax Margin-1.4%0.5%7.5%1.7%14.6%
Income Tax Expense(13.13M)5.89M(11.3M)6.86M27.44M
Net Income5.28M(2M)90.95M14.01M177.69M
Net Margin0.7%-0.2%8.6%1.2%12.7%
EPS (Basic)0.14(0.05)2.370.364.57
EPS (Diluted)0.14(0.05)2.320.364.52
Weighted Avg Shares36.76M37.84M38.4M38.63M38.92M
Weighted Avg Shares (Diluted)37.88M37.84M39.22M39.27M39.29M

Penumbra, Inc.

NYSE:PEN

Intrinsic Alpha fair value

Locked

Current Price

$320.60

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.